Filing Flows › Biolife Solutions (BLFS) › Capital expenditures
Biolife Solutions (BLFS) capital expenditures by quarter
Biolife Solutions' capital expenditures were $1.0M in Q2 2026 (second quarter 2026), +190% from Q3 2025. Over the last 4 quarters it ranged from $175K (Q1 2025) to $1.7M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.0M | +190% | -40% |
| Q3 2025 | $360K | -79% | — |
| Q2 2025 | $1.7M | +896% | — |
| Q1 2025 | $175K | — | — |
Q2 2026 at a glance
Biolife Solutions, Q2 2026: revenue $28.5M (+22% year over year), operating margin 6.0%, net earnings $45.1M, operating cash flow $6.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Biolife Solutions' capital expenditures?
Biolife Solutions' capital expenditures were $1.0M in Q2 2026 (second quarter 2026), +190% from Q3 2025.
How has Biolife Solutions' capital expenditures changed?
Over the last 4 quarters it ranged from $175K (Q1 2025) to $1.7M (Q2 2025).